We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Key Organics and RBC Announce Library Screening Format
News

Key Organics and RBC Announce Library Screening Format

Key Organics and RBC Announce Library Screening Format
News

Key Organics and RBC Announce Library Screening Format

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Key Organics and RBC Announce Library Screening Format"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Key Organics Ltd (Key) and Reaction Biology Corporation (RBC) have announced that they have teamed up to provide a library screening format to customers. 

Beginning this summer, the entire Key Bionet library of 37,500 diverse drug-like compounds will be offered for "rental" screening on RBC’s DiscoveryDot™ platform. 

Customers will be able to screen the Key library without having to purchase it outright. 

"While we have many large pharma clients who wish to purchase compounds directly, we see an unmet need in smaller pharma and biotech companies that want to screen one or more of their targets without investing in a library purchase," said Colin Piper, Business Development Manager for Key. 

"RBC’s platform gave us an economical way to reach these potential customers. Now researchers who do not have a budget for library purchases can still afford library screening."

The Key library will be screened locally at RBC’s lab facilities in Malvern PA. RBC will reformat the library to its microarray-based platform. 

"Our nanoliter-scale screening process means that we can we offer lower costs to customers, while our partnership with Key provides a clear path to additional chemistry expansion," said Tom Festa, National Sales Manager for RBC.

Advertisement